Rheumatoid arthritis—common origins, divergent mechanisms
EM Gravallese, GS Firestein - New England Journal of Medicine, 2023 - Mass Medical Soc
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Terapéutica farmacológica actual para artritis reumatoide, factores para su eficacia y complicaciones asociadas: revisión sistemática
J Rocha - Interdisciplinary Rehabilitation/Rehabilitacion …, 2024 - ri.saludcyt.ar
Rheumatoid arthritis (RA) is a chronic, autoimmune, and systemic inflammatory disease that
mainly affects diarthrodial joints. Its global prevalence is 0.5-1% in adults, increasing to 5 …
mainly affects diarthrodial joints. Its global prevalence is 0.5-1% in adults, increasing to 5 …
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Objectives To develop EULAR recommendations for screening and prophylaxis of chronic
and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases …
and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases …
[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …
ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
Nanomedicine is more than a supporting role in rheumatoid arthritis therapy
Y Han, S Huang - Journal of Controlled Release, 2023 - Elsevier
Rheumatoid arthritis (RA) is an autoimmune disorder that affects the joints. Various
medications successfully alleviate the symptoms of RA in clinical. Still, few therapy strategies …
medications successfully alleviate the symptoms of RA in clinical. Still, few therapy strategies …
Rosmarinic acid nanomedicine for rheumatoid arthritis therapy: Targeted RONS scavenging and macrophage repolarization
B Lu, C Li, L Jing, F Zhuang, H Xiang, Y Chen… - Journal of Controlled …, 2023 - Elsevier
The infiltration of inflammatory cells, especially macrophages, integrated with the production
of reactive oxygen and nitrogen species (RONS) and the release of inflammatory cytokines …
of reactive oxygen and nitrogen species (RONS) and the release of inflammatory cytokines …
The efficacy of denosumab in patients with rheumatoid arthritis: a systematic review and pooled analysis of randomized or matched data
Q Hu, X Zhong, H Tian, P Liao - Frontiers in Immunology, 2022 - frontiersin.org
Objective The purpose of this study was to evaluate the efficacy of denosumab treatment in
patients with rheumatoid arthritis (RA). Methods The Medline, Embase and Cochrane …
patients with rheumatoid arthritis (RA). Methods The Medline, Embase and Cochrane …
From science to success? Targeting tyrosine kinase 2 in spondyloarthritis and related chronic inflammatory diseases
D Hromadová, D Elewaut, RD Inman, B Strobl… - Frontiers in …, 2021 - frontiersin.org
Spondyloarthritis (SpA) is a family of inflammatory arthritic diseases, which includes the
prototypes of psoriatic arthritis and ankylosing spondylitis. SpA is commonly associated with …
prototypes of psoriatic arthritis and ankylosing spondylitis. SpA is commonly associated with …
Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
Y Zhang, J Lin, Z You, H Tu, P He, J Li, R Gao… - Frontiers in …, 2022 - frontiersin.org
Background Exploring the cancer risks of rheumatoid arthritis (RA) patients with disease-
modifying anti-rheumatic drugs (DMARDs) can help detect, evaluate, and treat malignancies …
modifying anti-rheumatic drugs (DMARDs) can help detect, evaluate, and treat malignancies …
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists
S D'angelo, F Atzeni, M Benucci, G Bianchi… - Frontiers in …, 2023 - frontiersin.org
Background Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease
involving several articular and extra-articular structures. Despite the important progresses …
involving several articular and extra-articular structures. Despite the important progresses …